Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 3 1Phase 1 1

Status

Completed 19Terminated 8Unknown 7Recruiting 6Withdrawn 3Not yet recruiting 3Active not recruiting 2

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 7

Sponsor

Cancer Type

Gynecologic 3Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 50Carcinoma, Non-Small-Cell Lung 36Ovarian Neoplasms 35Stomach Neoplasms 31Esophageal Neoplasms 26Uterine Cervical Neoplasms 20Esophageal Squamous Cell Carcinoma 18Fallopian Tube Neoplasms 16Lung Neoplasms 13Carcinoma, Ovarian Epithelial 13Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Neoplasms 8Carcinoma, Squamous Cell 8Recurrence 7Neoplasm Metastasis 6Endometrial Neoplasms 6Advanced Gastric Cancer 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Nasopharyngeal Neoplasms 5Hypopharyngeal Neoplasms 4Oropharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Laryngeal Neoplasms 3Carcinoma 3Anus Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 11Rituximab 10Gemcitabine 9Paclitaxel 7Lenalidomide 7Decitabine 7Cytarabine 7Bendamustine Hydrochloride 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Carboplatin 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Antilymphocyte Serum 4tislelizumab 3pomalidomide 3liposomal doxorubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × Recurrence × Paclitaxel × Clear all
NCT03467178 2021-09-05

MITO29

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
119 enrolled

Recurrence

NCT01650376 2018-03-23

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Swedish Medical Center

Phase 1/2 Unknown
52 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence, Uterine Neoplasms

NCT03026881 2017-03-07

A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Unknown
24 enrolled
Gastrointestinal

Recurrence, Stomach Neoplasms

NCT02492503 2015-07-08

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

All India Institute of Medical Sciences

Phase 1/2 Unknown
40 enrolled
Gynecologic

Uterine Cervical Neoplasms, Recurrence

NCT02435186 2015-05-06

p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 2 Unknown
100 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT01405235 2012-04-12

AGO-Zervix-1

Institut fuer Frauengesundheit

Phase 3 Unknown
312 enrolled

Recurrence

NCT00786552 2011-01-20

Panthera

University Hospital Schleswig-Holstein

Phase 2 Unknown
47 enrolled
EndocrineHead & Neck

Recurrence, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡